Podcast Episodes
Back to SearchWalmart Launches Mood & Mind Shelf, Boots Nears Weston Deal
Walmart just gave mood and mind beverages their own shelf — and the Weston family may be about to take control of Boots. Two structural retail shifts…
8 hours ago
Superdrug Goes 24/7, Grindr Buys Health Platform for $250M
Superdrug just became an always-on supplement retailer via Just Eat — and Grindr spent $250M to own a healthcare channel. Both moves redefine where h…
1 day, 8 hours ago
Huel Banned by ASA, Mulberry Targets Gut Health
Huel just got a public ruling from the UK ad watchdog — and it's a warning for every functional brand making video content. Plus mulberry science, br…
2 days, 8 hours ago
The Health Marketing Daily | Perelel Health hits $100 million run | California enacts non-ultraprocessed label despite food | Research highlights health trends that are
The Health Marketing Daily — September 30, 2026 In this episode: • A women's supplement brand hitting nine-figure revenue and poaching a prestige bea…
3 days, 8 hours ago
Unilever Bets on Beauty-Wellness Merger, GLP-1s Go Lifestyle
Unilever just told the market that beauty and wellness are one category — and GLP-1 manufacturers are now chasing the same consumer positioning your …
4 days, 8 hours ago
Glucosamine Alzheimer's Risk & McDonald's GLP-1 Menu Bet
McDonald's just named GLP-1 users a core menu audience with an $8B commitment — and glucosamine, one of Europe's top joint supplements, is now linked…
5 days, 8 hours ago
Calcium & Vitamin D Fail, Little Spoon Enters Supplements
A landmark meta-analysis is shaking the bone health supplement category, Little Spoon is converting food trust into supplement revenue, and GLP-1 dru…
6 days, 8 hours ago
McDonald's Bets $8B on Ozempic Era, Red Bull vs. Kroger
McDonald's just spent $8 billion signalling that GLP-1 drugs have permanently changed food strategy. If the world's biggest QSR is reformulating, sup…
1 week ago
GLP-1 Kids Gap, REWE Backs Longevity & Apothékary Goes Experiential
REWE's buyers have put longevity on the official retail agenda — and new GLP-1 research just opened an uncontested paediatric supplement niche. If yo…
1 week, 1 day ago
Ozempic Stopped & Heart Risk Rebounds
Stopping Ozempic rebounds heart risk — and that's a direct opening for supplement brands. Plus AB InBev is moving into functional beverages, and when…
1 week, 2 days ago